Total Payments
$8,923
2024 Payments
$5,745
Companies
8
Transactions
16
Medicare Patients
465
Medicare Billing
$64,862
Payment Breakdown by Category
Consulting$7,430 (83.3%)
Other$888.99 (10.0%)
Food & Beverage$539.32 (6.0%)
Education$64.50 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,430 | 3 | 83.3% |
| Grant | $888.99 | 1 | 10.0% |
| Food and Beverage | $539.32 | 11 | 6.0% |
| Education | $64.50 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $6,683 | 5 | $0 (2024) |
| Eisai Inc. | $1,914 | 5 | $0 (2023) |
| TESARO, Inc. | $107.09 | 1 | $0 (2019) |
| GlaxoSmithKline, LLC. | $64.50 | 1 | $0 (2024) |
| Ethicon US, LLC | $52.15 | 1 | $0 (2022) |
| Clovis Oncology, Inc. | $49.99 | 1 | $0 (2017) |
| Genmab U.S., Inc. | $35.17 | 1 | $0 (2023) |
| Aadi Bioscience, Inc. | $17.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,745 | 3 | AstraZeneca Pharmaceuticals LP ($5,680) |
| 2023 | $2,862 | 8 | Eisai Inc. ($1,872) |
| 2022 | $117.62 | 2 | AstraZeneca Pharmaceuticals LP ($65.47) |
| 2021 | $41.30 | 1 | Eisai Inc. ($41.30) |
| 2019 | $107.09 | 1 | TESARO, Inc. ($107.09) |
| 2017 | $49.99 | 1 | Clovis Oncology, Inc. ($49.99) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,255.00 | General |
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Consulting Fee | Cash or cash equivalent | $3,425.00 | General |
| Category: Oncology | ||||||
| 09/09/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Education | In-kind items and services | $64.50 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $15.35 | General |
| Category: Oncology | ||||||
| 10/28/2023 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $35.17 | General |
| Category: Oncology | ||||||
| 10/27/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $48.80 | General |
| Category: Oncology | ||||||
| 10/26/2023 | Aadi Bioscience, Inc. | Fyarro (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cancer | ||||||
| 10/04/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $14.06 | General |
| Category: Oncology | ||||||
| 09/13/2023 | Eisai Inc. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: Oncology | ||||||
| 06/22/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $92.94 | General |
| Category: Oncology | ||||||
| 06/01/2023 | AstraZeneca Pharmaceuticals LP | — | Grant | Cash or cash equivalent | $888.99 | General |
| 11/04/2022 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $65.47 | General |
| Category: Oncology | ||||||
| 04/04/2022 | Ethicon US, LLC | STRATAFIX (Device) | Food and Beverage | In-kind items and services | $52.15 | General |
| Category: Wound Closure | ||||||
| 09/09/2021 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $41.30 | General |
| Category: Oncology | ||||||
| 09/24/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $107.09 | General |
| Category: ONCOLOGY | ||||||
| 09/09/2017 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 168 | 321 | $40,909 | $21,757 |
| 2022 | 6 | 158 | 283 | $75,868 | $27,975 |
| 2021 | 4 | 116 | 220 | $24,741 | $12,730 |
| 2020 | 2 | 23 | 40 | $5,337 | $2,399 |
Total Patients
465
Total Services
864
Medicare Billing
$64,862
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 26 | 84 | $12,658 | $8,827 | 69.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 60 | 97 | $7,063 | $4,025 | 57.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 32 | 32 | $6,496 | $3,819 | 58.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 68 | $8,908 | $2,483 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 21 | 28 | $2,880 | $1,869 | 64.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 11 | 12 | $2,904 | $734.76 | 25.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 27 | 69 | $10,842 | $7,753 | 71.5% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 11 | 11 | $40,843 | $7,409 | 18.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 38 | 38 | $8,105 | $5,126 | 63.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 24 | 43 | $4,972 | $2,987 | 60.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 32 | 61 | $4,453 | $2,686 | 60.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 40 | $5,120 | $1,189 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 21 | $1,533 | $825.66 | 53.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 30 | 30 | $6,174 | $4,377 | 70.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 58 | $4,064 | $2,604 | 64.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 28 | 49 | $3,560 | $2,388 | 67.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 22 | 63 | $6,363 | $1,755 | 27.6% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 14 | 20 | $4,580 | $1,607 | 35.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 12 | 12 | $2,485 | $1,507 | 60.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 11 | 28 | $2,852 | $892.40 | 31.3% |
About Dr. Allison Puechl, MD
Dr. Allison Puechl, MD is a Gynecologic Oncology healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2013. The National Provider Identifier (NPI) number assigned to this provider is 1245572528.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Allison Puechl, MD has received a total of $8,923 in payments from pharmaceutical and medical device companies, with $5,745 received in 2024. These payments were reported across 16 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($7,430).
As a Medicare-enrolled provider, Puechl has provided services to 465 Medicare beneficiaries, totaling 864 services with total Medicare billing of $64,862. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Obstetrics & Gynecology
- Location Charlotte, NC
- Active Since 03/25/2013
- Last Updated 07/15/2024
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1245572528
Products in Payments
- ENHERTU (Biological) $3,425
- Lenvima (Drug) $1,914
- ZEJULA (Drug) $171.59
- LYNPARZA (Drug) $114.27
- STRATAFIX (Device) $52.15
- Rubraca (Drug) $49.99
- Tivdak (Drug) $35.17
- Fyarro (Drug) $17.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.